(Q38540657)

3 September 2017

1 reference

title

How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma? (English)

1 reference

3 September 2017

1 reference

Charles Swanton

3

0 references

author name string

Aspasia Soultati

1

1 reference

3 September 2017

Mark Stares

2

1 reference

3 September 2017

James Larkin

4

1 reference

3 September 2017

Samra Turajlic

5

1 reference

3 September 2017

publication date

1 September 2015

1 reference

Current Opinion in Urology

3 September 2017

published in

1 reference

3 September 2017

volume

25

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

358-366

1 reference

Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy

3 September 2017

cites work

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/1078-0432.CCR-13-2345

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1097/MOU.0000000000000204

1 reference

3 September 2017

1 reference